The company is partnering with Beijing University Cancer Hospital and Konica Minolta in a clinical trial to assess the efficacy of scalp cooling for chemotherapy-induced hair loss in women with breast cancer.
Dr. Tao Ouyang, Chairman of Breast Center of Beijing University Cancer Hospital will lead the study which includes 256 patients at Beijing University Cancer Hospital over the course of approximately six months.
“This is a very important first step in our commitment to bring DigniCap to the Asian market in conjunction with our distribution partner Konica Minolta,” said William Cronin, Chief Executive Officer of Dignitana AB. “As of yet there is no data from a clinical study of scalp cooling with an exclusively Asian population. Beijing Cancer Hospital is a leading cancer treatment facility in Asia and we are eager to work with them in this milestone study.”
FDA clearance since 2015
Konica Minolta is Dignitana’s distribution partner in Asia and a natural choice as a partner to bring this product to Asia, reports the company. The DigniCap Scalp Cooling System has had clearance from the U.S. Food and Drug Administration since 2015.